Dolby Laboratories (DLB) is down sharply Friday, May 1, 2026, as investors focus on forward guidance rather than the quarter that just ended. While the company reported fiscal Q2 2026 results that topped expectations, Dolby’s fiscal Q3 2026 outlook implied a steep sequential slowdown, which is pressuring the stock.

For fiscal Q2 2026, Dolby reported revenue of $395.6 million and non-GAAP diluted EPS of $1.37. However, for fiscal Q3 2026 the company guided revenue to $295–$325 million and non-GAAP EPS to $0.56–$0.71, a setup that signals a large quarter-to-quarter deceleration and reset in near-term earnings power even as the company maintained its full-year FY2026 revenue outlook of $1.40–$1.45 billion and non-GAAP EPS outlook of $4.30–$4.45.

DLB’s move reflects the market’s sensitivity to visibility and royalty timing in a high-margin licensing model. A Q3 guide that lands well below prior expectations can outweigh a Q2 beat because it affects near-term revenue cadence, operating leverage, and the confidence investors place on the remaining quarters needed to hit full-year targets. Dolby also flagged macro, supply-chain, and trade-related uncertainties as factors affecting visibility, reinforcing the cautious reaction.

Traders will watch for signs that the Q3 shortfall is primarily timing-related (deal closures, customer product cycles, or royalty recognition patterns) versus a demand issue in core end markets like mobile, PC, streaming, and automotive. Investors will also monitor capital returns—Dolby reiterated its $0.36 quarterly dividend payable May 20, 2026 and continued buybacks—as potential support if the company can re-accelerate results later in fiscal 2026.